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Abstract
The use of cyclosporine A (CsA) is limited by its severe nephrotoxicity that includes reversible vasoconstrictor effects and
proximal tubule cell injury, the latter associated whith chronic kidney disease progression. The mechanisms of CsA-induced
tubular injury, mainly on the S3 segment, have not been completely elucidated. Kidney androgen-regulated protein (KAP) is
exclusively expressed in kidney proximal tubule cells, interacts with the CsA-binding protein cyclophilin B and its expression
diminishes in kidneys of CsA-treated mice. Since we reported that KAP protects against CsA toxicity in cultured proximal
tubule cells, we hypothesized that low KAP levels found in kidneys of CsA-treated mice might correlate with proximal tubule
cell injury. To test this hypothesis, we used KAP Tg mice developed in our laboratory and showed that these mice are more
resistant to CsA-induced tubular injury than control littermates. Furthermore, we found that calpain, which was activated by
CsA in cell cultures and kidney, is involved in KAP degradation and observed that phosphorylation of serine and threonine
residues found in KAP PEST sequences by protein kinase CK2 enhances KAP degradation by calpain. Moreover, we also
observed that CK2 inhibition protected against CsA-induced cytotoxicity. These findings point to a novel mechanism for
CsA-induced kidney toxicity that might be useful in developing therapeutic strategies aimed at preventing tubular cell
damage while maintaining the immunosuppressive effects of CsA.
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Introduction
Kidney androgen-regulated protein (KAP) is a highly specific,
tightly regulated protein of kidney proximal tubule cells [1]. We
studied KAP transcriptional regulation in mouse kidney and
reported a fine-tuned regulation of its mRNA by thyroid and
sexual steroid hormones, growth hormone (GH) and insulin-like
growth factor 1 (IGF-1) in proximal tubule segments [1–8]. The
absence of significant homologies with other proteins or with
known structural domains has greatly reduced the experimental
approaches to elucidate KAP function, which has remained elusive
since first described in 1979 [9]. Previously, using specific
antibodies raised against KAP-derived synthetic peptides, we
identified an apparent 20kDa molecular-weight protein that
paralleled KAP mRNA in terms of cell distribution and androgen
regulation [10]. We also found that KAP interacts with the
cyclosporine A (CsA) binding protein cyclophilin B (CypB) [10],
and observed that KAP protein levels are lowered in kidneys of
CsA-treated mice [10]. Moreover, KAP protected from CsA-
induced toxicity when transfected to the proximal tubule-derived
PCT3 cell line [10].
The great clinical benefits of CsA in the improvement of graft
survival rates in organ transplantation are associated with
significant undesirable nephrotoxic effects that include reversible
vasoconstriction and proximal tubule cell injury, the latter
associated with chronic kidney disease progression [11–13]. The
mechanisms underlying CsA-induced toxicity in proximal tubule
cells have not been completely elucidated. Morphologic evidence
suggests that early sublethal tubular damage is confined to the S3
segment of the proximal tubule [14]. Since KAP is exclusively
expressed in proximal tubules, we hypothesized that suboptimal
KAP levels after CsA treatment could relate to homeostatic and/
or metabolic alterations which, affecting proximal tubule cell
function, could lead to cell injury and death.
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The present report aimed to determine the putative protective
effect of KAP in vivo using a KAP transgenic mouse model that
overexpresses KAP in proximal tubule cells 15]. Moreover, we
focused on elucidating the mechanisms that promote CsA-
dependent KAP degradation, and hypothesized that post-transla-
tional mechanisms such as phosphorylation/dephosphorylation-
related events could contribute to control of physiological KAP
levels modulation of its degradation.
Results
KAP Tg mice are protected against CsA-induced tubular
damage
We aimed to ascertain whether raised KAP levels in Tg mice
would attenuate CsA-induced damage in proximal tubule cells. To
this end, various doses of CsA were tested to select that which
would produce tubular injury without clinical kidney damage in an
attempt to observe the early effects of CsA on proximal tubule
cells. Augmented SCr and BUN, together with interstitial tubular
fibrosis, would reflect a clinical situation where early effects of CsA
on tubular epithelia would be overdue. Early tubular injury can be
assessed by expression of the kidney injury marker KIM-1 and the
cell proliferation marker PCNA [16–18]. A 50 mg/kg/day dose
of CsA was found to fulfill the exclusive tubular damage criteria
when administered to animals fed either a standard diet for 28
days or a low salt diet for 21 days. SCr and BUN levels were
unaffected under these CsA treatment conditions (Table S1), while
KIM-1 and PCNA expression increased upon CsA administration
in both standard and low-salt diet regimens in control littermates
(Fig. 1A and 1B left panels). Quantitative results are represented in
Figures 1C and 1D. KAP Tg mice exposed to the same treatments
that caused tubular injury in littermates did not express KIM-1
(Fig. 1 right panels, and Fig. 1C) and no changes were observed in
PCNA levels (Fig. 1B left panels, and Fig. 1D), thereby indicating
that KAP protects proximal tubule cells from CsA-induced toxicity
in vivo. Since KIM-1 and PCNA expression levels were unaffected
by the type of diet in vehicle-treated mice (Fig. 1C and 1D), only a
single representative picture for vehicle-treated control mice (VH)
was included (Fig. 1A and 1B).
Results showed that in CsA-treated Tg mice, KAP levels in the
S3 segment remained similar to those observed in vehicle-treated
control littermates (Fig 2A and 2B). Quantification of the degree of
KAP overexpression under control conditions and following
different CsA treatments was made by using the ImageJ software,
as indicated in Methods (Fig 2B). Since KIM-1 and PCNA levels
were not increased in CsA-treated Tg mice (See Figure 1), we
postulate that maintenance of KAP levels in proximal tubule cells
prevents Tg mice from CsA-induced tubular damage.
CsA activates calpain and caspases in mouse kidney and
cultured proximal tubule cells
Since KAP levels appeared to be critical in CsA-induced
toxicity, we aimed to investigate the mechanisms involved in KAP
degradation. Previous analysis of the KAP primary sequence
reported a putative PEST sequence encompassing 83–102 residues
3]. More detailed analysis using the epestfind program (http://
emboss.bioinformatics.nl/cgi-bin/emboss/epestfind) revealed a
new PEST sequence between residues 53 and 89 with a PEST
score of 6.35 (Fig. 3A). PEST sequences have been associated with
proteins with a short half-life, and act as recognition signals for
degradation via proteosome or calpain. Calpain activation was
then analyzed by western blot assays in crude kidney extracts from
CsA-treated mice using endogenous a-fodrin as a reporter. Results
showed that, after CsA treatment, a-fodrin became cleaved in a
pattern characteristic of calpain and caspases activation (150/
145 kDa and 120 kDa fragments, respectively) (Fig. 3B) 19,20].
Since CsA activates calpain and caspases in mouse kidney and
KAP is degraded in response to this immunosuppressant (Fig 2),
we aimed to ascertain whether calpain and caspases contributed to
CsA-induced KAP degradation. To this end, we used the PCT3
proximal tubule cell line [8,10] and determined the effects of the
calpain inhibitor MDL28170 and the pan caspase inhibitor Z-vad-
FMK on KAP stability. As shown in Fig 3C, KAP levels were
significantly preserved in the presence of both inhibitors, thereby
suggesting that CsA-induced KAP degradation might be mediated
by calpain and caspases in this cell line.
Protein kinase CK2 is involved in KAP phosphorylation in
cultured cells
PEST sequences are frequently conditional signals, and the
protein is not recognized until it is ‘‘marked’’ for degradation [21].
Phosphorylation is one of the molecular mechanisms described for
activating this process [22]. In this respect, Prosite sequence
analysis predicted Thr60, Thr66 and Thr87 within the PEST
sequence as potential phosphorylation sites for protein kinase
CK2, fulfilling the minimal consensus sequence for this kinase
(Ser/Thr-X-X-Asp/Glu). Ser65 and Ser86 can also be considered
as potential CK2 sites according to the requirements fulfilled by
other CK2 phosphorylated proteins [23] (Fig. 3A). All these sites
were also predicted to be CK2 phosphorylation sites by the
NetPhosK 1.0 Server. These data suggest that CK2 phosphory-
lation of KAP could favor its degradation. Thus, we aimed to
ascertain whether KAP was phosphorylated in transiently-
transfected PCT3 cells metabolically labeled with [32P]orthophos-
phate. Labelled-immunoprecipitates showed radioactive phos-
phate incorporation into a protein (Fig. 4A, left panel) recognized
by specific anti-KAP antibodies (Fig. 4A, right panel). Mock-
transfected cells were negative, thereby demonstrating that KAP
phosphorylation was specific.
To determine whether CK2 was the kinase responsible for KAP
phosphorylation, KAP-WT transfected PCT3 cells were exposed
to the CK2 inhibitors apigenin and DRB for one hour prior to
exposure of the cells to [32P]orthophosphate and for the ensuing
three hours of metabolic labelling. Both inhibitors reduced KAP-
WT phosphorylation (Fig. 4B). In order to further demonstrate
CK2 involvement in KAP phosphorylation, we carried out CK2a
siRNA-based experiments using KAP-WT transfected PCT3 cells
and showed that KAP phosphorylation decreased around one-half
when CK2a expression was reduced to 50% (Fig. 4C).
The ability of CK2 to phosphorylate KAP was also demon-
strated in vitro using recombinant His-KAP-purified protein and
recombinant CK2a or the reconstituted holoenzyme CK2(a2/b2)
(Fig. 5A and B). Stoichiometry analysis, with increasing quantities
of His-KAP protein (0.1 to 0.5 mg) incubated with the holoenzyme
to maximum phosphorylation (30 min), showed that CK2
incorporated up to 2.9 mols of phosphate/mol of His-KAP,
therefore indicating the presence of at least three CK2
phosphorylation sites in KAP protein (Fig. 5C).
KAP is phosphorylated at residues located in the PEST
sequence
As mentioned above, our results indicate the presence of at least
three CK2 phosphorylation sites in the KAP protein. A panel of
mutants was generated and phosphorylation analyzed in 32P-
labeled PCT3 transfected cells to map KAP phosphorylation sites
within the PEST sequence. Site-directed mutagenesis was
performed using the KAP wild-type sequence (KAP-WT).
KAP Prevents CsA-Induced Proximal Tubule Injury
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Individual phosphorylation site mutants (Fig. 6A) and ST65/66AA
and ST86/87AA double-site mutants (Fig. 6B) were tested. S65A
and T66A each reduced KAP phosphorylation by around 30%,
while the ST65/66AA double mutant provoked 60% inhibition.
Similarly, individual S86A and T87A mutations each reduced
phosphorylation by 10%, while ST86/87AA mutations decreased
by aproximately 30%. The T60A mutant reduced KAP
phosphorylation by around 20%. These data indicated that two
phosphorylation domains, Thr60 and Ser65/Thr66, placed in the
most N-terminal PEST sequence, exhibited the strongest impact
on KAP phosphorylation. To confirm this point, mutants
including T60A and ST65/66AA mutations (KAP-DM) or
residues T60A, ST65/66AA and ST86/87AA, resulting in the
PEST-free sequence KAP-TM form, were tested. Phosphorylation
of KAP-DM and KAP-TM was as low as 20% and 10%,
respectively (Fig. 6C). The residual phosphorylation/radioactivity
observed in KAP-TM could be attributable to other CK2
phosphorylation sites located outside the PEST region. Immuno-
precipitation with anti-phospho-Thr antibodies of KAP-WT and
KAP-TM in transfected PCT3 cell extracts confirmed that the
Thr residues mutated in KAP-TM participate in KAP-WT
phosphorylation (Fig. 6D).
Cyclosporine A-induced KAP degradation is affected by
PEST sequences integrity
Next, we wondered whether CsA-induced KAP degradation
would be influenced by KAP-phosphorylation. Dose-response CsA
treatment showed KAP-TM to be was more resistant than KAP-
WT (Fig. 7A). Time-course studies showed that in the absence of
CsA, KAP-WT and KAP-TM levels were similar and remained
stable for 9 h (Fig. 7B, left panel). By contrast, in the presence of a
10 mM CsA dose, KAP-WT decreased more rapidly than KAP-
Figure 1. KAP Tg mice are protected from CsA-induced tubular damage. Expression levels of KIM-1 (A) and PCNA (B) were assessed by
immunohistochemical staining in kidney sections of KAP Tg and control littermates treated with CsA, as indicated in Figure 1. Data shown are
representative of six animals per group. Magnification: 400x. Quantitative analysis of KIM-1 positive tubules (C) and of PCNA-positive cells (D) of
treatment conditions depicted in (A) and (B), respectively, are graphically represented. The number of PCNA-positive cells and KIM-1 positive tubules
in each section was determined by counting positively stained cells or tubules in 10 randomly chosen fields (x 200 magnification) per slide. Data
represent means6 SD of six animals per group. The littermate-CsA group has more KIM-1 positive tubules, for both standard (p,0.0001) and low-salt
(p,0.0001) diets, compared to the littermate-VH, KAP Tg-VH and KAP Tg-CsA groups. Similarly, the littermate-CsA group has more PCNA positive
tubules, for both standard (p,0.0001) and low-salt (p,0.0002) diets, compared to the littermate-VH, KAP Tg-VH and KAP Tg-CsA groups (ANOVA,
with Tukey post-hoc test). *Significantly higher than KAP Tg-CsA.
doi:10.1371/journal.pone.0025746.g001
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TM (Fig. 7B, right panel). These results indicated that CsA-
mediated KAP degradation occurs in a dose- and time-dependent
manner and that the effects were increased in the presence of
intact PEST sequences in KAP.
Calpain-mediated KAP degradation is favored by PEST
sequences
As mentioned above, KAP phosphorylation sites for CK2 are
inserted in PEST sequences which act as recognition signals for
degradation by calpain. In an attempt to confirm calpain activation
in response to CsA in PCT3 cells, a specific substrate that becomes
fluorescent upon calpain-mediated degradation (t-Boc-LM-CMAC,
Molecular Probes) was used in these cells. CsA treatment promoted
calpain activation (Fig. 8A), which was specifically abrogated by the
selective calpain inhibitor MDL28170 (Fig 8B).
In intact cells, calpain exists in cytosol as an inactive enzyme
and translocates to membranes in response to increases in cellular
Ca2+ level [24]. Our results show, that in PCT3 cell extracts,
KAP-WT or KAP-TM were equally stable in the absence of Ca2+
(Fig. 8C, lanes 2 and 3). The presence of CaCl2 provoked strong
decay in KAP-WT (Fig. 8C, lane 4) that was dose-dependently
reversed by the concomitant presence of EDTA (Fig. 8C, lanes 5
and 6). Since effects were less prominent on KAP-TM, we
hypothesized that disruption of PEST motifs partially protected
KAP from degradation by an endogenous Ca2+-dependent
protease. The pattern of a-fodrin degradation confirmed endog-
enous calpain activation (Fig. 3B). Moreover, the calpain selective
inhibitor MDL 28170 prevented KAP and a-fodrin degradation in
the presence of 5 mM CaCl2 (Fig. 8C, lane 7).
To further assess whether KAP-WT and KAP-TM had
different calpain sensitivity, cell-free extracts from transiently-
transfected PCT3 cells were incubated with purified recombinant
m-calpain for different time periods (Fig. 8D). Under these
conditions, KAP-WT and KAP-TM were also degraded by m-
calpain, with KAP-TM being more resistant to proteolysis than
KAP-WT (Fig. 8D). The different sensitivity of KAP-TM and
Figure 2. KAP levels in KAP Tg and control littermates after CsA treatment. (A) KAP expression levels were assessed by
immunohistochemical staining in kidney sections of KAP Tg and control littermates using specific anti-KAP antibodies. Polyclonal antibodies
against KAP were raised by rabbit immunization with the NH2-CPKIPLAGNPVSPTS-CONH2 KAP peptide. Mice were treated with CsA (50 mg/kg/day)
for 28 days with standard diet or 21 days with a low-salt diet, as indicated in Fig 1. Vehicle-treated mice are marked as VH. Data shown are
representative of six animals per group. Magnification: 40x. (B) Quantification of KAP levels in Tg and littermates, under control conditions and
following different injuries, using the ImageJ software (ImageJ 1.44p, National Institutes of Health, Bethesda, Maryland, USA). Data represent means6
SD of six animals per group. There are statistical significant differences for both standard (p,0.0001) and low salt (p,0.0001) diets, being littermate-
CsA KAP levels (*) lower than the others groups, and KAP Tg-VH KAP levels (**) higher than the other groups (ANOVA, with Tukey post-hoc test).
doi:10.1371/journal.pone.0025746.g002
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KAP-WT to proteolysis was also assessed in intact cultured PCT3
cells treated with CaCl2 and increasing doses of ionophor A23187
in the absence or presence of MDL 28170. KAP-WT was
degraded in the presence of ionophor A23187, in a dose-
dependent manner (Fig. 8E, lanes 1 to 5), which was blocked by
MDL 28170 (Fig. 8E, lanes 6 and 7). In these assays, KAP-TM
was more resistant to degradation than KAP-WT. In summary,
these findings shown in Figure 8 demonstrate that KAP is a target
for calpain and that the mutation of PEST sequences significantly
prevents KAP proteolysis mediated by this protease.
KAP degradation by calpain in vitro is enhanced by CK2
phosphorylation
To determine whether KAP phosphorylation by CK2 would
affect KAP degradation in vitro, and further demonstrate that
phosphorylation rather than residue substitution in itself affected
Figure 3. CsA activates calpain and caspases in kidney and cultured proximal tubule cells. (A) KAP protein analysis using the epestfind
program (http://emboss.bioinformatics.nl/cgi-bin/emboss/epestfind) identified a new putative PEST sequence (PEST 1) between residues 53 and 89.
This adds to the known putative PEST sequence (PEST 2) reported previously between residues 83 and 102. (B) Protease activation in mice treated
with olive oil (vehicle) or CsA at 80 mg/kg/day for 14 days was analyzed by Western blot assay in crude kidney extracts. Degradation of a-fodrin (240-
kDa) into the 150/145 kDa and 120 kDa fragments was determined to assess endogenous calpain and caspase activities, respectively. (C) KAP stability
was analyzed in PCT3 transfected cells treated for 3, 6 and 9 h with CsA 10 mM alone or in combination with either calpain or caspase inhibitors
(MDL28170 or Z-VAD-FMK, respectively). Actin levels were monitored as protein loading control (upper panel). Normalized densitometric values of
the western blot signals are shown in the lower panel of Fig 3C. The amount of KAP at time 0 h was taken as the 100% in each case. Values at
different times were referred to as a percentage of the total initial protein. *Significantly higher than the time-paired control (Student-t test, p,0,05).
doi:10.1371/journal.pone.0025746.g003
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KAP degradation, in vitro assays using recombinant His-KAP
protein and rat recombinant m-calpain were performed in the
presence of 5 mM CaCl2. His-KAP was incubated with CK2 in
phosphorylation buffer prior to the addition of calpain, and
degradation compared with results obtained with non-phosphor-
ylated His-KAP (Fig. 9A). Our results show that His-KAP
incubated with CK2 was degraded more extensively than the
non-phosphorylated one. In conclusion, these experiments show
the recombinant KAP protein to be a good substrate for calpain
and that phosphorylation by CK2 increases its degradation.
Recombinant His-KAP protein was incubated with m-calpain
in the presence of EDTA or the specific calpain inhibitor MDL
28170 to further confirm that direct KAP degradation in the
absence of CK2 phosphorylation was due to calpain (Fig. 9B). The
presence of EDTA in the assay buffer completely blocked His-
KAP degradation by m-calpain, thereby demonstrating absolute
Ca2+ dependence for efficient KAP degradation. The specific
calpain inhibitor MDL 28170 completely blocked substrate
degradation, even in the presence of the protease (Fig. 9B).
CK2 inhibitors prevent CsA toxicity in proximal tubule
cells
Once demonstrated that: i) KAP diminishes CsA-induced
toxicity, ii) KAP is phosphorylated by CK2 and iii) calpain-
Figure 4. Protein kinase CK2 is involved in KAP phosphorylation in cultured cells. (A) Transient transfected PCT3 cells with an empty
vector (mock) or containing the KAP-WT construct were metabolically labeled with [32P]orthophosphate. Cell lysates were immunoprecipitated with
the anti-HA antibody and the products resolved in an SDS-PAGE, transferred to a PVDF membrane and exposed to an X-ray film (left panel). Western
blot with specific anti-KAP-1 antibodies demonstrates that the phosphorylated protein was KAP (right panel). (B) KAP-WT transfected PCT3 cells were
exposed to the CK2 inhibitors apigenin and DRB for one hour before exposure of the cells to [32P]orthophosphate and for the ensuing three hours of
metabolic labeling. Densitometric autoradiographic values were referred to values of Western blot assays performed with an anti-KAP antibody (left
panel). The percentage of phosphorylation inhibition obtained in the presence of apigenin and DRB, in relation to the control situation, is graphically
represented (right panel). *Significantly lower than control (Student-t test, p,0,05). (C) PCT3 cells were co-transfected with KAP-WT and either non-
silencing control (siRNA con) or anti-CK2a siRNA. After 48h of transfection, the cells were exposed to [32P]orthophosphate, labeled for 3h and
processed as indicated in (A). *Significantly lower than siRNA control (Student-t test, p,0,05).
doi:10.1371/journal.pone.0025746.g004
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dependent degradation of KAP is favored by CK2 phosphory-
lation, we wondered what the effect of CK2 and calpain
inhibitors would be on cell viability upon CsA treatment. MDL
28170 calpain inhibitor, apigenin and DRB CK2 inhibitors, at
the pre-established non-toxic doses, were used on KAP
transfected PCT3 cells to determine their effect on CsA-induced
toxicity. As shown in Fig 10 (upper part), both CK2 inhibitors,
apigenin and DRB, protect cells from toxicity. Unexpectedly,
although MDL 28170 in itself is non-toxic, it became toxic in
combination with CsA (lower panel Fig 10). Consequently,
although this calpain inhibitor would preserve KAP degradation,
its use would not be recommended owing to its toxic effects when
combined with CsA.
Discussion
Since CsA constitutes a very potent therapeutic tool, better
understanding of the molecular mechanisms underlying undesir-
able kidney toxicity would be extremely important from a clinical
point of view. While renal vasoconstriction is a characteristic of
acute CsA toxicity and is largely reversible with dose reduction
[25], an irreversible decline in kidney function associated with
structural changes may also be observed after long-term CsA use
[26]. Although the molecular mechanisms of CsA toxicity have not
been completely elucidated, clinical and experimental studies have
provided accumulated evidences for a direct effect of CsA on
proximal tubule epithelial cells [27,28] that has been associated
with chronic renal failure [29]. Morphologic evidence suggests
Figure 5. KAP is a substrate for protein kinase CK2 in vitro. (A) Ability of CK2 to phosphorylate KAP in vitro using mouse recombinant His-KAP-
purified protein as substrate and recombinant purified CK2 as the kinase in the presence of [-32P]ATP (Amersham Biosciences). Products were
resolved in a 15% SDS-PAGE and visualized with Coomassie Blue staining. Phosphorylated His-KAP recombinant protein was detected by
autoradiography. (B) Time-course phosphorylation assay. 0.5 mg of His-KAP purified protein were incubated in the presence of 2 pmols of the
holoenzyme. Products were resolved in a 15% SDS-PAGE and visualized with Coomassie Blue staining. Phosphorylated His-KAP recombinant protein
was detected by autoradiography (left). Ratios between autoradiographic and Coomassie densitometric signals were graphically represented (right).
(C) Stoichiometry of the His-KAP phosphorylation. Increasing amounts of mouse recombinant His-KAP-purified protein were incubated for 30 min in
the presence of 2 pmols of the holoenzyme. CK2 was able to incorporate up to 2.9 mols of phosphate/mol of His-KAP, indicating that there are at
least three sites that can be phosphorylated by the kinase.
doi:10.1371/journal.pone.0025746.g005
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that early sublethal tubular damage is confined to the S3 segment
of the proximal tubule [14]; however the reason for this specificity
has not been unraveled. Results presented in this paper indicate
that CsA-induced downregulation of KAP, which occurs specif-
ically in the S3 segment, is associated with expression of kidney
injury marker KIM-1. Moreover, threshold maintenance of KAP
levels achieved in CsA-treated KAP Tg mice protects against the
tubular injury observed in control littermates. KIM-1 is more
sensitive and represents a much earlier kidney injury marker than
SCr, BUN and urinary NAG in multiple rat models of kidney
injury, thereby indicating that KIM-1 measurements may facilitate
sensitive, specific and accurate prediction of nephrotoxicity in
preclinical drug screening [18]. Significant KIM-1 overexpression
in chronic CsA nephropathy characterized by tubular injury in
rats has also been observed [30]. Our results suggest that KAP
exerts a protective effect in vivo, and that KAP degradation by CsA
might represent a novel mechanism that underlies CsA-induced
toxicity in the S3 segment of the proximal tubule. Understanding
KAP degradation mechanisms would be extremely useful for
developing new therapeutic strategies to prevent CsA toxicity in
the kidney while maintaining their immunosuppressive effects.
Previous analysis of the KAP primary sequence reported a
putative PEST sequence encompassing 83–102 residues [3]. A
more detailed analysis revealed a new PEST sequence between
residues 53 and 89 with a pest score of 6.35. PEST sequences are
rich in proline (P), glutamic acid (E), serine (S) and threonine (T)
residues, are associated with proteins with a short half-life, and act
as signals for degradation via proteosome or calpain. Some PEST
Figure 6. In cultured kidney cells KAP, is phosphorylated at residues located in the PEST sequence. (A) Residues Thr60, Ser65, Thr66,
Ser86 and Thr87 were mutated and KAP phosphorylation analyzed in 32P-labeled PCT3 cells overexpressing KAP mutants. Numbers in the lower panel
of Fig. A and in the following panels were calculated by densitometric analyses of phosphorylated protein and normalized by total KAP protein levels.
The ratio corresponding to KAP-WT protein was used as a reference in each case. * p,0,05 vs WT (Student-t test). (B) Individual domains that include
T60A, ST65/66AA and ST86/87AA were also tested. As depicted in Fig. B, all three constructs resulted in a reduction in KAP phosphorylation. * p,0,05
vs WT (Student-t test). (C) New mutants that include T60A and ST65/66AA (KAP-DM) and residues T60A, ST65/66AA and ST86/87AA (KAP-TM) were
also produced. The phosphorylation capacities of DM and TM constructs were assessed as explained in part A of this figure. * p,0,0001 vs WT
(Student-t test).(D) Immunoprecipitation of KAP-WT and KAP-TM in transfected PCT3 cell extracts using anti-phospho-Thr antibodies (##), and
further immunoblotting with anti-KAP specific antibodies showed that the Thr residues mutated in the KAP-TM form are phosphorylated in the WT
form. Immunoprecipitation of KAP-WT cell extracts using anti-CycE antibodies was used as a negative control (#).* p,0,0001 vs WT (Student-t test).
doi:10.1371/journal.pone.0025746.g006
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sequences appear to be constitutive proteolytic signals, as for
example, the carboxyl terminus of mouse ODC [22]. However,
many PEST sequences are conditional signals, and can be
activated in a number of ways [22]. Different molecular
mechanisms, such as ligand binding [31], exposure to light and
phosphorylation [22] have been described as activating this
process. The paradigm of PEST-containing protein regulated by
phosphorylation might be I| Ba. PEST-dependent I| Ba
degradation involves CK2 phosphorylation of serine/threonine
residues within the PEST domain of I| Ba that triggers calpain-
mediated degradation [32]. Thus, we wondered whether KAP
degradation occurred by a process similar to I| Ba. Our results
show that calpain is activated by CsA both in vitro and in vivo and
that calpain is involved in CsA-induced KAP cleavage. Calpains
are intracellular cysteine proteases that play crucial roles in basic
physiologic and pathologic processes [24]. Calpain has been
reported to mediate ischemic/hypoxic injury in brain [33], kidney
[34], liver [35] and myocardium [19]. Cytoprotection by calpain
inhibitors has been observed during hypoxia in rat renal proximal
tubules [36], cerebrocortical neurons [37] and rat hepatocytes
subjected to anoxia. Calpain inhibitors have also been found to be
effective in blocking cell death induced by a diverse group of
toxicants in rat and rabbit proximal tubules [38]. Calpains are
calcium-dependent proteases and, as for ischemic injury, levels of
intracellular calcium have proved to play an important role in CsA
toxicity [39,40]. Reduction in extracellular calcium levels in the
media or addition of calcium entry antagonists protected against
CsA-induced cell damage [41]. Moreover, expression of calbindin-
D28K, a cytosolic calcium binding protein, in cultured mouse
proximal tubular cells protects against CsA toxicity, most likely
through its buffering effects on intracellular calcium [42]. Since
the critical substrates of calpains during cell injury/death remain
unidentified, we postulate that KAP might be a potential target for
understanding the molecular mechanisms underlying injury in
proximal tubule cells.
The KAP PEST sequence presents residues Thr60, Thr66 and
Thr87 as potential phosphorylation sites for CK2. Ser65 and
Ser86 can also be considered potential CK2 sites according to the
requirements fulfilled by other CK2 phosphorylated proteins [23].
CK2 is a ubiquitous, constitutively-active Ser/Thr protein kinase
with a great diversity of substrates involved in a wide range of
cellular functions [23,43]. Several short-life proteins containing
PEST sequences have been found phosphorylated by CK2 [44–
46]. Our results show that CK2 phosphorylated KAP in cultured
PCT3 cells and in vitro phosphorylation assays. Site-directed
mutagenesis of residues located in KAP PEST sequences reduced
KAP-TM mutant (T60A, ST65/66AA and ST86/87AA) phos-
phorylation levels to 10% of those found in KAP-WT. Moreover,
mutation of these residues strongly diminished the PEST score of
these sequences. We observed that KAP-TM was more resistant
than KAP-WT in the following experimental conditions: i) cell-
free extracts in the presence of calcium; ii) cell-free extracts
incubated with purified recombinant m-calpain; iii) intact cultured
cells incubated with calcium in the presence of the ionophore
A23187; and iv) intact cells treated with CsA. Taken together,
these results support the involvement of PEST sequences in KAP
recognition by calpain. It is noteworthy that in all the cases
mentioned above, KAP-TM was still partially degraded, which
suggests that residues other than those mutated in the KAP-TM
could contribute to calpain-mediated KAP degradation.
The implication of CK2 phosphorylation in KAP degradation
was reinforced by the fact that His-KAP incubated with CK2 was
degraded more extensively than the non-phosphorylated His-
KAP. Since the latter was also degraded when exposed to calpain,
Figure 7. Cyclosporine A-induced KAP degradation is affected by PEST sequence integrity. (A) PCT3 cells transfected with the KAP-WT or
the KAP-TM mutant vectors were treated with increasing doses of CsA (0, 1, 2.5, 5, 10 and 15 mM) for 20h. KAP protein levels in cell lysates were
analyzed by western blot using anti-HA antibodies. PVDF membranes were stained with Coomassie Blue as a loading control (not shown). Normalized
densitometric values of the western blot signals are shown in the right panel. Amount of KAP-WT and KAP-TM at time 0 h were taken as 100% in each
case. Values at different times were referred to as a percentage of the total initial protein. * p,0,05 and ** p,0,001 vs dose-paired KAP-WT
transfected cells (Student-t test).(B) Time-course study on KAP stability from a 1 to 9 h time period, using a single dose of CsA (10 mM) in PCT3 cells
transfected with the KAP-WT or the KAP-TM mutant vectors. KAP protein was analyzed as in (A).
doi:10.1371/journal.pone.0025746.g007
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Figure 8. Calpain-mediated KAP degradation is favored by PEST sequences. (A) PCT3 cells were treated with 10 mM CsA for 3, 6 and 9 h
and the fluorescence calpain substrate t-Boc-LM-CMAC (20 mM) was added for the last 45 min. Calpain activity was then analyzed by fluorescent
microscopy. (B) PCT3 cells were treated with CsA 10 mM for 6 h alone or in presence of the calpain inhibitor MDL28170 (10 mM). Calpain activity was
measured as above. (C) Transiently-transfected PCT3 cells with expression constructs containing the KAP-WT or the KAP-TM mutant were lysed and
protein extracts prepared. Extracts were incubated in assay buffer containing 5 mM CaCl2, 5 or 10 mM EDTA and/or 10 mM of MDL 28170. KAP and a-
fodrin proteins were detected by western blot using antibodies against the HA epitope or specific anti-a-fodrin antibodies. The right panel represents
the signal quantifications, taking as 100% the densitometric values detected at time 0. * p,0,01 and ** p,0,001 vs treatment-paired KAP-WT
transfected cells (Student-t test). (D) Transiently-transfected PCT3 cells with constructs expressing KAP-WT or KAP-TM were lysed 24h after
transfection and crude extracts incubated with the purified m-calpain enzyme for different times. Steady-state protein levels of recombinant KAP-WT
and KAP-TM or the endogenous a-fodrin were determined by Western blot assays. The activity of m-calpain was demonstrated by the efficient
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our results suggest that although KAP degradation by calpain is
enhanced by CK2 phosphorylation, this is not an absolute
requirement. The role of PEST sequences underlying calpain
substrate recognition is not fully understood. Mutations of PEST
regions either abrogate substrate sensitivity to calpain [31,47] or
have no effect at all [48,49]. Moreover, a significant fraction of
calpain substrates have no PEST region at all [49]. Calpains are
puzzling in that their requirement for calcium in vitro is
considerably greater than most estimates of cytosolic calcium levels
[49]. It was initially proposed that PEST regions could sequester
calcium because of their negative charge and thereby present
calpains not only with susceptible bonds but with the required co-
factor as well [50]. In this respect, CK2 phosphorylation within
PEST sequences could bring, through phosphate group addition to
targeted residues, extra negative charges that could enhance
calcium sequestration and thus foster calpain activation.
This work provides a novel mechanism for CsA-induced toxicity
in proximal tubule cells based on KAP degradation by calpain,
favored by CK2 phosphorylation of KAP PEST sequences. KAP-
mediated protection against CsA-induced injury in proximal tubule
cells, both in KAP Tg mice and in KAP transfected cells in culture,
indicates that mechanisms either promoting KAP expression or
preventing KAP degradation could represent specific therapeutic
approaches to protecting proximal tubule cells from CsA damage
and cardiovascular-related events. We previously reported that
KAP Tg mice show hypertension and renal alterations including
focal segmental glomerulosclerosis, proteinuria, glycosuria, and
fibrosis [15]. While this phenotype appears at 6 to 8 months of age,
likely due to sustained chronic KAP over-expression and increased
oxidative stress exposure, the younger KAP Tg mice used in the
present study did not show any sign of injury at 10–14 weeks of age,
as observed by KIM-1 expression (Fig 1). The fact that sub-optimal
KAP levels correlate with proximal tubule cell injury in CsA-treated
mice or that supra-optimal KAP levels promote augmented
oxidative stress and hypertension in Tg mice indicates the
importance of maintaining KAP levels under tight regulated
control. Besides the complex transcriptional regulatory mechanisms
that control KAP mRNA levels in the kidney, we propose herein
that KAP degradation by calpain after CK2 phosphorylation
represents a novel layer of fine-tuning control on KAP protein levels
and, therefore, a potent system to quickly respond to pathophys-
iologic demands. Furthermore, we propose that both KAP and
CK2 could represent new therapeutic targets to ameliorate CsA
toxicity in proximal tubule cells of the kidney.
Materials and Methods
Ethics statement
All studies were in compliance with the rules of the European
Union and the US Department of Health and Human Services
Guide for the Care and Use of Laboratory Animals. All
procedures were approved by the authors’ Institutional Review
Board on Animal Health: Comite` E`tic de Experimentacio´ Animal
(CEEA) Hospital Universitari Vall d’Hebron. Permit Number FIS
PI08/1351.
DNA constructs
The pHA-KAP-HA mammalian expression vector contains the
KAP cDNA. Site-directed mutagenesis was performed by PCR
using the pHA-KAP-HA as template and overlapping primers
encoding the mutations, following the manufacturer’s instructions.
Mutations were verified by DNA sequencing.
KAP was also subcloned into pET-14b (Novagen) with a His6
tag in the N-terminal domain (pET-14b/KAP). Human CK2a
and CK2b subunits were cloned in pQE-30 vector 51]. KAP,
CK2a and CK2b proteins were expressed in Escherichia coli and
purified as described 52].
Cell culture, transfection and siRNA experiments
PKSV-PCT (PCT3 clone) were cultured and transfected as
described 7,8]. CK2a siRNA oligonucleotides were from Qiagen
and silencing performed as indicated. CK2a evels were detected
with anti-CK2a antibodies (Santa Cruz Biotechnologies).
Phosphorylation assays in cultured cells
pHA-KAP-HA transfected cells were labeled in vivo with
[32P]orthophosphate (Amersham Biosciencies) in the presence,
where indicated, of protein kinase CK2 inhibitors Apigenin and
DRB (5,6-dichlorobenzimidazole riboside) (Sigma). Lysate super-
natants, incubated with anti-HA high-affinity antibody (Roche
Molecular Biochemicals), were precipitated with slurry protein G-
Sepharose and proteins transferred to PVDF membranes. 32P-
labeled KAP-HA was detected by autoradiography. Membranes
were then incubated with anti-KAP antibodies and the blot was
developed using chemiluminescence (ECL Plus, Amersham Phar-
macia Biotech) and exposed to X-ray film (Kodak). Quantifications
were made with a BioRad GS800 Calibrated Densitometer and
ImageQuant software (Molecular Dynamics) and phosphorylation
normalized by dividing the radioactivity incorporated (into KAP-
HA) by the immunoreactive density of KAP-HA.
Alternatively, transfected cells were lysed in precipitation buffer
and immunoprecipitated with anti-pThr antibody or anti-CycE
antibody (negative control). Immunoblotting was performed with
anti-KAP. 1 mg of total cell lysate protein was also loaded onto the
gel and labeled as the INPUT.
KAP stability after CsA treatments
Eighteen hours post-transfection, PCT3 cells expressing KAP-WT
or KAP-TM were treated with increasing doses of CsA (Sandinmun,
Roche) (0, 1, 2.5, 5, 10 and 15 mM) for 20 h. Protein levels in extracts
were examined by Western blot with anti-HA antibody. KAP stability
was also analyzed in transfected cells incubated with 10 mM CsA at
different time points alone or in combination with either calpain or
caspase inhibitors (MDL28170 or Z-VAD-FMK, respectively).
In vitro degradation assay
Lysates from transfected cells were incubated with digestion
buffer, with or without 5 mM CaCl2, in the presence or not of
EDTA or MDL 28170. In another set of experiments, extracts
were incubated with purified recombinant m-calpain in digestion
degradation of the a-fodrin protein upon exposure to the enzyme. Quantification assessed by densitometric analysis is represented in the right-hand
panel of figure C. * p,0,01 vs time-paired KAP-WT transfected cells (Student-t test). (E) PCT3 cells transiently transfected with the KAP-WT and the
KAP-TM constructs were exposed to increasing doses of ionophor A23187 and 5 mM CaCl2, in the absence or presence of the specific calpain
inhibitor MDL 28170. Twenty-four hours post-transfection, and after 45 min of calpain activation treatment, cells were lysed and extracts analyzed by
western blot assays to determine steady-state KAP levels. The 150/145 a-fodrin proteolyzed fragments appear under conditions that prompted
activation of endogenous calpain in the cells. As above, densitometric analyses of western blots are represented in the lower panel of the figure. The
situation control in each case was taken as 100% of protein expression levels and used as a reference for the remaining treatments. * p,0,01 vs dose-
paired KAP-WT transfected cells (Student-t test).
doi:10.1371/journal.pone.0025746.g008
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buffer (containing CaCl2). Reactions stopped at various time
points were resolved by Western blot using anti-HA or anti-a-
fodrin antibodies. For in vitro KAP phosphorylation and degrada-
tion assays, recombinant His-KAP samples were incubated in
kinase buffer in absence or presence of the CK2 holoenzyme [53].
His-KAP was digested with recombinant m-calpain in digestion
buffer with CaCl2 alone or in the presence of EDTA or MDL
28170. Reactions were stopped by addition of SDS-PAGE loading
buffer and electrophoresed . Proteins were visualized by gel
Coomassie Brilliant Blue staining.
Calpain activity assays
pHA-KAP-HA transfected cells were washed with PBS, treated
with increasing doses of A23187 (Sigma) and 5mM CaCl2 in
Figure 9. KAP degradation by calpain in vitro is enhanced by CK2 phosphorylation. (A) CK2 phosphorylation promotes in vitro degradation
of KAP by calpain. 0.5 mg of mouse recombinant His-KAP-purified protein were incubated in the presence (lanes 5 to 8) or absence (lanes 1 to 4) of 2
pmols of CK2a2/b2 and ATP for 30 min. To each reaction, 0.18 U of m-calpain were added and incubated in assay buffer containing 5 mM CaCl2 for 0,
2, 5 and 10 min. Reactions were stopped by addition of loading buffer and products run in a 15% SDS-PAGE. Proteins were visualized by Coomassie
Blue staining and graphic representation after densitometric analysis shown in the lower panel of the figure. It represents the normalized signal
quantifications, taking as 100% the densitometric values detected at time 0. * p,0,05 and ** p,0,01 vs time-paired His-KAP incubated in the absence
of CK2a2/b2 (Student-t test). (B) Non-phosphorylated KAP degradation is due to calpain. 0.5 mg of mouse recombinant His-KAP-purified protein were
incubated with 0.18 U of m-calpain in assay buffer containing 5 mM CaCl2, at different times; in these same conditions, at the 10 min time, 10 mM
EDTA (lane 5) or 10 mM of MDL 28170 (lane 6) were also added. Degradation was visualized by Coomassie Blue in SDS-PAGE and quantification
assessed by densitometric analysis (lower panel). * p,0,001 vs untreated His-KAP (Student-t test).
doi:10.1371/journal.pone.0025746.g009
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absence or presence of MDL 28170 and lysed with RIPA buffer.
Protein extracts were analyzed by Western blot with anti-HA and
anti-a-fodrin antibodies.
To assay the direct effect of CsA on calpain activation, PCT3
cells were plated at 50-80% confluence on glass coverslips for 24h
and then treated with CsA 10 mM from 0 to 9h, in the presence of
t-Boc-LM-CMAC (20 mM, Molecular Probes) for the last 45min.
Samples were observed under a fluorescent microscope (excitation
329nm, emission 409nm). Calpain-catalyzed cleavage of Boc-LM-
CMAC creates a fluorescent product. The fluorescence intensity of
the samples correlates with calpain activity.
Animal experimental protocol
Ten to 14-week-old male KAP-Tg mice and their littermates
(15), were treated for 28 days with vehicle alone (n = 6) or CsA
50 mg/kg/day by subcutaneous injection (n = 6). Another group of
animals received a low-salt diet (0.01% sodium, Harlan, Tekland)
and, after one week, a daily subcutaneous injection of CsA 50 mg/
kg/day (n = 6) or vehicle alone (n = 6) for 21 days.
Mice were euthanized and kidneys obtained from each animal
for further analysis, in accordance with the requirements of the
Spanish Government and the European Community (Real
Decreto 1201/2005: B.O.E. no. 252. 21/10/2005).
Functional studies
Serum was collected by cardiac puncture at the time of
euthanasia. Serum creatinine (SCr) and serum blood urea nitrogen
(BUN) were determined at the Clinical Biochemistry Service of the
Veterinary Hospital of the Universitat Auto`noma de Barcelona.
Immunohistochemical analysis
Tissue sections were analyzed by indirect immunoperoxidase
staining as previously described [15] with anti-KAP and anti-PCNA
monoclonal antibodies (Santa Cruz Biotechnology). Goat anti-KIM1
polyclonal antibody (R&D Systems) was detected using the LSAB
staining method (Dako LSAB+ System-HRP) following the manu-
facturer’s protocol. The number of PCNA- and KIM-1-positive
tubules in each section was determined by counting positively-stained
cells or tubules in 10 randomly chosen fields (x 200 magnification) per
slide. KAP levels in Tg mice and littermates, under control conditions
and following different injuries, were quantified using the ImageJ
software (ImageJ 1.44p, National Institute of Health, Bethesda,
Maryland, USA) [54,55]. Statistical analysis of the staining intensity
was made using an ANOVA one-way test for each diet , followed by a
least significant difference post-hoc test (STATGRAPHICS Plus
statistical package, Statistical Graphics Corp.).
Cell viability assay
CsA cytotoxicity was measured by LDH release assay using a
commercial kit (LDH kit, Roche,
Mannheim, Germany) according to the manufacturer’s instruc-
tions. The released LDH is expressed as the percentatge of total
LDH measured after lysis of the cells.
Western blot analysis
Kidneys were homogenized in lysis buffer (40 mM Tris-HCl,
4% CHAPS, 8 M Urea). Western blot analysis was performed
with anti-KAP polyclonal antibody [15], anti-actin monoclonal
antibody (Sigma) and anti-a-fodrin monoclonal antibody (Biomol
International). The protein content of cellular extracts was
quantified by the Bradford assay. Total cell extract protein was
run on SDS-PAGE gels, transferred onto PVDF membranes and
incubated with the corresponding antibodies. The membranes
were developed with the enhanced chemiluminescence method
(Pierce, Rockford, IL, USA).
Statistical Analyses
Statistical analysis of staining intensity in kidney tissue sections
was made using an ANOVA one-way test for each diet, followed
by a Tukey post-hoc test. Results from figures 3, 4, 5, 6, 7, 8, 9,
and 10 are expressed as mean 6 SEM (standard error of the
mean) of at least three independent experiments. Statistical
analyses were performed with commercially-available software
(Statgraphics Plus, Manugistics, Rockville, MD, USA).
Supporting Information
Table S1 Percent change of functional parameters in
each group in respect to vehicle.
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Figure 10. CK2 inhibitors prevent CsA toxicity in proximal
tubule cells. The CK2 inhibitors apigenin and DRB (A) and the calpain
inhibitor MDL 28170 (B) were used, at the pre-established non-toxic
doses (50 mM for apigenin and DRB, and 5 or 10 mM for MDL 28170), on
KAP transfected PCT3 cells to determine their effects on CsA-induced
toxicity, measured by LDH release assays. The released LDH is expressed
as the percentatge of total LDH measured after lysis of the cells. The
data are then expressed taking the value of inhibitor or vehicle treated
cells as 100% and are the mean 6 S.E.M of three different experiments.
* p,0,05 vs CsA-treated pKAP control transfected PCT3 cells (Student-t
test).
doi:10.1371/journal.pone.0025746.g010
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